In vitro diagnostic drug testing for pancreatic cancer granted MNOK 16 in support

2023-Dec Our project for in vitro diagnostic drug testing for pancreatic cancer was granted MNOK 16 in support through the Innovation Project for the Industrial Sector program. The project is a collaboration with Hybrid Technology Hub and Sahlgrenska University Hospital.